NCT05247151View on ClinicalTrials.gov

The Association of Affective Resonance With Empathy Modulated by Negative Symptomatology and Oxytocin

NACompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

August 2, 2021

Primary Completion Date

November 25, 2021

Study Completion Date

January 30, 2022

Conditions
Schizophrenia Spectrum Disorders
Interventions
OTHER

Oxytocin

Oxytocin nasal spray in a positive social setting.

OTHER

Placebo

Placebo nasal spray in a positive social setting.

Trial Locations (1)

12203

Charité Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin

All Listed Sponsors
lead

Charite University, Berlin, Germany

OTHER

NCT05247151 - The Association of Affective Resonance With Empathy Modulated by Negative Symptomatology and Oxytocin | Biotech Hunter | Biotech Hunter